Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Regeneration Stories

2011-10-13 10:25:22

New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks. At least 20 million people survive heart attacks and strokes every year, according to World Health Organization estimates, but many have poor life expectancy and require continual costly clinical care.  The use of patient´s own stem cells may repair heart attacks, although their benefit may be limited due to scarce availability and ageing.  The...

2011-10-03 14:06:00

NEW YORK, Oct. 3, 2011 /PRNewswire/ -- Hearing Health Foundation, long at the forefront of trailblazing initiatives in hearing and balance science, today hosted the 2011 Summit: The Promise of Cell Regeneration, the first public-focused health conference bringing together the nation's leaders in the field of cell regeneration research in the ear to discuss current research and potential therapies to restore hearing through the Hearing Restoration Project (HRP). To view the multimedia...

2011-09-29 07:00:00

Aderans Research experts shared their findings across the country this month, from Atlanta to Alaska. Distinguished representatives from the hair regeneration institute were invited to present at two prestigious conferences: the International Society of Hair Restoration Surgery (ISHRS) 19th Annual Scientific Meeting and the Georgia Life Sciences Summit 2011. Atlanta, GA (PRWEB) September 29, 2011 Aderans Research experts shared their findings across the country this month, from Atlanta to...

2011-09-14 07:30:00

EAST NORRITON, Pa., Sept. 14, 2011 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that Brian Davis, Vice President Finance and Chief Financial Officer of Tengion, will present at the upcoming UBS Global Life Sciences Conference on Monday, September 19, 2011, at 1:30 pm EDT. A live webcast of the presentation can be accessed under "Calendar of Events" in the Investors section of the Company's website at www.tengion.com or by accessing...

2011-09-07 07:30:00

EAST NORRITON, Pa., Sept. 7, 2011 /PRNewswire/ -- Tengion, Inc (NASDAQ: TNGN), a leader in regenerative medicine, today announced that Brian Davis, Vice President and Chief Financial Officer of Tengion, will present at the upcoming Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13, 2011, at 1:35 pm EDT. A live webcast of the presentation can be accessed under "Calendar of Events" in the Investors section of the Company's website at www.tengion.com or by...

2011-09-06 07:00:00

CAMBRIDGE, Mass., Sept. 6, 2011 /PRNewswire/ -- SyntheMed, Inc. ("the Company") (OTCBB: SYMD; Pink Sheets: SYMD) and Pathfinder, LLC, a private biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today announced the completion of their merger, effective September 2, 2011. The Company changed its name to "Pathfinder Cell Therapy, Inc.", and the stock will continue to trade on the OTC Bulletin Board, changing to a new trading symbol...

Could Stem Cells Cure Baldness?
2011-09-02 05:33:26

  Researchers from Yale University may have found a genetically natural cure for baldness - stem cells that tell a person's hair when it's time to grow. According to the scientists, these stem cells are the source of the signals that trigger hair growth and are found within the fatty layer of the skin. They report that they were able to use these cells as a catalyst to grow hair in mice--a discovery that could eventually lead to new treatment for those who have lost or are...

2011-08-15 07:30:00

EAST NORRITON, Pa., Aug. 15, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN) today announced that it has appointed Diane Jorkasky, M.D., who recently joined Endo Pharmaceuticals (Nasdaq: ENDP) as Senior Vice President, Clinical Development and Chief Medical Officer, to its Board of Directors. Tengion also announced today that Brenda Gavin, D.V.M., Managing Partner at Quaker BioVentures, is stepping down from the Tengion Board of Directors after five years of service. Quaker BioVentures...

0c3bb7c25ac89bb5ef718525a9a8d3c1
2011-08-11 06:25:00

Flatworms provide new insight into organ regeneration and the evolution of mammalian kidneys Our bodies are perfectly capable of renewing billions of cells every day but fail miserably when it comes to replacing damaged organs such as kidneys. Using the flatworm Schmidtea mediterranea"”famous for its capacity to regrow complete animals from minuscule flecks of tissue"”as an eloquent example, researchers at the Stowers Institute for Medical Research demonstrated how our distant...

2011-08-09 12:14:34

Study has implications for reprogramming human cardiac myocytes to replace damaged heart muscle Stem cell researchers at UCLA have uncovered for the first time why adult human cardiac myocytes have lost their ability to proliferate, perhaps explaining why the human heart has little regenerative capacity. The study, done in cell lines and mice, may lead to methods of reprogramming a patient's own cardiac myocytes within the heart itself to create new muscle to repair damage, said Dr. Robb...